Buzz on the Bullboards: Where volatility meets opportunity

Some indices hit lows not seen in nearly a year after a concerning inflation report, only to bounce back the next day.

Telo Genomics kick-starts clinical trial for multiple myeloma patients

Telo Genomics has kick-started its clinical trial for multiple myeloma patients after receiving the first patient sample from the trial.

Theralase donates laser therapy tech to help research Parkinson’s treatment

Theralase Technologies (TSXV:TLT) has donated some of its technology to help advance university studies into Parkinson’s Disease treatment.

BioNxt reveals results from multiple sclerosis treatment study

BioNxt Solutions (CSE:BNXT) is one step closer to having its proprietary Cladribine product available to treat multiple sclerosis.

Avicanna locks in licensing deal with pharmaceutical company

Avicanna (TSX:AVCN) has announced an exclusive supply agreement for two of its proprietary topical products with a pharmaceutical company.

Microcap stock Datametrex adds new chapter to turnaround story

Microcap stock Datametrex AI is building upon its recent change in corporate focus with the creation of a new AI-based entertainment division.

HEALWELL AI acquires Intrahealth for $24.2 million

Healthcare technology company HEALWELL AI Inc. (TSX:AIDX) has completed its acquisition of Intrahealth Systems Ltd.

Beaten down microcap stock repaves path to profitability

Datametrex, a beaten down microcap stock, is announcing new changes to boost revenue, improve cash flow and streamline operations.
Filament Health Corp - Benjamin Lightburn, CEO and Co Founder

FDA investigating new psychedelic drug to treat substance abuse

The FDA has accepted Filament Health’s (NEO:FH) application for its psilocybin drug candidate to treat substance disorders.

Numinus Wellness offers turnkey exposure to psychedelic medicine

Stock investors searching for holistic exposure to psychedelic medicine should add Numinus Wellness to their due diligence lists.

Legal cocaine stock applauds Amsterdam mayor’s call for new narcotics regulation

Safe Supply Streaming (CSE:SPLY), a stock investing in legal cocaine, applauds a recent statement from Amsterdam Mayor Femke Halsema.
PharmAla Biotech - PharmAla's LaNeo MDMA capsules.

PharmAla approved to sell MDMA and psilocybin in Canada

Health Canada has cleared PharmAla Biotech (CSE:MDMA) to sell MDMA and psilocybin to anyone legally permitted to hold them.

Buzz on the Bullboards: Good stocks with bad publicity

Many markets may have seen a higher start to the year, but some companies had a rougher start to 2024 than others.
The Market Online Video

Medicus Pharma advances cancer treatment towards phase II trial

Medicus Pharma (TSXV:MDCX) CEO Raza Bokhari discusses plans for the company's non-invasive basal cell carcinoma treatment's clinical trial.

Optimi Health increases MDMA quantities, bets on FDA approval

Optimi Health (CSE:OPTI) has been granted the right to substantially increase the quantities of MDMA, MDA, and 2CB.

Introducing Canada’s first telehealth program for long COVID rehab

One in nine Canadian adults have endured long-term symptoms from a COVID-19 infection according to Statistics Canada.

Theralase provides encouraging bladder cancer study results

Theralase Technologies (TSXV:TLT) has announced positive bladder cancer study results from its Phase II non-muscle invasive clinical study.

Clearmind Medicine to advance alcohol use disorder treatment

Clearmind Medicine (CSE:CMND) has completed a Type A meeting with the FDA for its clinical trial of CMND-100 to treat alcohol use disorder.